A medical lab operating on a revenue share basis with a pharmaceutical partner is seeking clarity on Tax Deducted at Source (TDS) applicability. The arrangement involves the pharma partner providing space, with the lab liable for 20% of gross revenue. The discussion explores whether this falls under Section 194I (rent) or 194C (commission), with the latter suggested as potentially applicable based on the agreement's terms. GST implications at 18% are also confirmed.
18 June 2022
I am running a medical lab. For the expansion purpose, i have jointly operate medical lab with some other parties who are dealing pharma business(medical store) on r revenue share basis. Medical store provide some area of their building to us and we collect swab from there. As per our agreement we are liable to 20% of gross revenue to party. In this scenario, what section of TDS applicable.
20 June 2022
We have collect the amount as based on an revenue share agreement/contract. Is it covered u/s 194 I. Can we collect TDS u/s 194 C as based on this agreement.